73 unknown. 73 Phase 3, 21 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 73 | Unknown 73 |
| Phase 2 | 21 | Unknown 21 |
Follow Gastroenteritis: new trials by email Literature Review of Gastroenteritis trials Research Report on Gastroenteritis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Trial to Investigate the Efficacy and Safety of Ondansetron (Danset - Adwia) Versus Placebo Plus the Standard of Care in the Treatment of Nausea and Vomiting in Adult Patients With Acute Gastroenteritis Ondansetron 8 mg ampoule, Metoclopramide 10 mg ampoule - Gastroenteritis | Phase 3 | Unknown | Genuine Research Center, Egypt | 126 | 2025-06-01 | 2024-09-26 |
| Pharmacokinetics, Efficacy and Safety of CT-P13 Subcutaneous as Induction Therapy in Patients With Active CD or UC CT-P13 - Inflammatory Bowel Diseases | Phase 3 | Unknown | CMC Ambroise Paré | 130 | 2024-07-10 | 2024-07-31 |
| Unravelling Intestinal Fibrosis in Ulcerative Colitis Fibroblast Activation Protein Inhibitor - Ulcerative Colitis (UC), Inflammatory Bowel Disease (IBD) | Phase 2 / Phase 3 | Unknown | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 10 | 2024-04-03 | 2024-09-19 |
| Phase III Multicentre Trial of Oral Mesalazine in Patients With Mild to Moderate Ulcerative Colitis. Mesalazine - Colitis, Ulcerative | Phase 3 | Unknown | Faes Farma, S.A. | 376 | 2024-03-01 | 2023-12-19 |
| EffiCacy and sAfEty of Low doSe orAl iRon for Anaemia in IBD Ferrous fumarate syrup 2.5ml/70mg (22.5mg elemental iron), Ferrous fumarate syrup 2.5ml/70mg(45mg elemental iron), Ferrous fumarate syrup 2.5ml/70mg (90mg elemental iron) - Inflammatory Bowel Disease, Iron Deficiency Anemia | Phase 3 | Unknown | Liverpool University Hospitals NHS Foundation Trust | 30 | 2023-10-20 | 2024-03-20 |
| Efficacy, Safety and Immunogenicity of the Proposed Biosimilar Vedolizumab PB016 in Comparison With Entyvio® Intravenous (IV) infusions - Ulcerative Colitis | Phase 3 | Unknown | Polpharma Biologics S.A. | 750 | 2023-07-24 | 2025-06-17 |
| GastroIntestinal Panel in Kidney Transplant Patients FilmArray GI - Kidney Transplant; Complications, Diarrhoea;Acute | Phase 3 | Unknown | Assistance Publique - Hôpitaux de Paris | 135 | 2023-02-01 | 2023-02-22 |
| the Efficacy and Safety of Diosmin in Patients With Ulcerative Colitis Placebo, Diosmin - Ulcerative Colitis | Phase 3 | Unknown | Tanta University | 60 | 2022-12-15 | 2023-04-12 |
| Budesonide Multimatrix(MMX) Versus Prednisolone in Management of Mild to Moderate Ulcerative Colitis Budesonide MMX, Prednisolone - Ulcerative Colitis Chronic | Phase 2 / Phase 3 | Unknown | Assiut University | 100 | 2022-06-01 | 2022-04-22 |
| Exclusion Diet vs corticosteroIds in patientS With activE Crohn's Disease Crohn's disease exclusion diet (CDED), Oral prednisolone - Crohn Disease | Phase 2 / Phase 3 | Unknown | Assistance Publique - Hôpitaux de Paris | 80 | 2022-04-01 | 2022-03-17 |
| Efficacy, Immunogenicity and Safety of S. Flexneriza-S. Sonnei Bivalent Conjugate Vaccine in Volunteers Aged From 6 Months to 5 Years S. Flexneriza-S. Sonnei Bivalent Conjugate Vaccine, Placebo - Dysentery, Shigellosis | Phase 3 | Unknown | Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd | 21000 | 2021-12-11 | 2022-01-11 |
| A Phase 3 Study to Investigate the Efficacy and Safety of SHR0302 With Moderately to Severely Active Ulcerative Colitis SHR0302, Placebo - Ulcerative Colitis | Phase 3 | Unknown | Reistone Biopharma Company Limited | 368 | 2021-11-05 | 2023-09-05 |
| The Effect of Alpha Lipoic Acid on the Incidence and Severity of Radiotherapy-Induced Oral Mucositis in Head and Neck Cancer Patients Alpha Lipoic Acid 600 MG Oral Tablets, Placebo tablets, radiation or concurrent chemoradiation - Radiation-Induced Mucositis | Phase 2 / Phase 3 | Unknown | Ain Shams University | 70 | 2021-09-01 | 2021-08-27 |
| The Efficacy and Safety of a Compound Glutamine Capsule in the Primary Prevention of Chemotherapy-induced Mucositis a compound glutamine capsule/a compound glutamine capsule simulated placebo - Mucositis, Chemotherapeutic Toxicity | Phase 3 | Unknown | Meng Qiu | 108 | 2021-06-30 | 2021-10-25 |
| The Efficacy and Safety of a Compound Glutamine Capsule in the Prevention of Chemotherapy-induced Mucositis a compound glutamine capsule, a compound glutamine capsule simulated placebo - Mucositis, Chemotherapeutic Toxicity | Phase 3 | Unknown | Meng Qiu | 90 | 2021-06-30 | 2021-10-15 |
| Efficacy and Safety of Vedolizumab in Biologic-naïve Korean Patients With Moderate to Severe Inflammatory Bowel Disease Vedolizumab - Crohn's Disease and Ulcerative Colitis | Phase 3 | Unknown | Yonsei University | 60 | 2021-06-01 | 2021-06-09 |
| N-acetyl Cysteine for the Prevention of Oral Mucositis After Autologous Hematopoietic Cell Transplantation. N acetyl cysteine - Mucositis, Transplant-Related Disorder | Phase 3 | Unknown | moshe yeshurun | 116 | 2021-04-01 | 2021-02-16 |
| Exclusive Enteral Nutrition in Patients With Ileocaecal Crohn's Disease EEN (Nestle Modulen®), Standart of care - Crohn Disease, Nutrient; Excess | Phase 3 | Unknown | Duzce University | 256 | 2021-03-01 | 2022-10-18 |
| Treatment of Classic Mid-trimester PPROM by Means of Continuous Amnioinfusion Continuous amnioinfusion with Amnion Flush Solution through the intraamniotic catheter - Bronchopulmonary Dysplasia, Necrotizing Enterocolitis | Phase 3 | Unknown | Martin-Luther-Universität Halle-Wittenberg | 68 | 2021-01-01 | 2021-01-12 |
| Anastomotic Leakage and Value Of Indocyanine Green in Decreasing Leakage Rates ICG-guided bowel perfusion assessment - Colo-rectal Cancer, Crohn Disease | Phase 3 | Unknown | Leiden University Medical Center | 978 | 2020-07-01 | 2021-01-15 |
Showing 20 of 73. Sign in to see all of them.
Crohn Disease (24) · Colitis, Ulcerative (23) · Inflammatory Bowel Diseases (13) · Mucositis (10) · Enterocolitis, Necrotizing (4) · Anemia, Iron-Deficiency (3) · Gastritis (3) · Stomatitis (3) · Anemia (2) · Appendicitis (2) · Bronchopulmonary Dysplasia (2) · Colitis, Collagenous (2) · Colonic Neoplasms (2) · Diarrhea (2) · Diverticular Diseases (2)
Digestive System Diseases (72) · Gastrointestinal Diseases (72) · Intestinal Diseases (57) · Inflammatory Bowel Diseases (33) · Colonic Diseases (28) · Colitis (25) · Pathological Conditions, Signs and Symptoms (13) · Mouth Diseases (10) · Stomatognathic Diseases (10) · Infections (7) · Pathologic Processes (6) · Neoplasms (5) · Neoplasms by Site (5) · Enterocolitis (4)
Azathioprine (6) · Mesalamine (5) · Adalimumab (4) · Fecal Microbiota Transplantation (4) · Amoxicillin (3) · Clarithromycin (3) · Prednisolone (3) · Rifaximin (3) · Budesonide (2) · Cholecalciferol (2) · Infliximab (2) · Mercaptopurine (2) · sucrosomial iron (2) · Acetylcysteine (1) · Adenosine Triphosphate (1)
Sixth Affiliated Hospital, Sun Yat-sen University (4) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (3) · Asian Institute of Gastroenterology, India (2) · Assistance Publique - Hôpitaux de Paris (2) · Bonderup, Ole K., M.D. (2) · Charite University, Berlin, Germany (2) · Hamamatsu University (2) · Meng Qiu (2) · University of Aarhus (2) · Acibadem University (1) · Aga Khan University (1) · Ain Shams University (1) · American University of Beirut Medical Center (1) · Assiut University (1) · Associazione Chirurghi Ospedalieri Italiani (1)
China (8) · Netherlands (5) · United States (5) · Denmark (4) · India (4) · Italy (4) · Turkey (Türkiye) (4) · France (3) · Germany (3) · Israel (3) · Japan (3) · Egypt (2) · Georgia (2) · Poland (2) · South Korea (2)
Rupa Banerjee, MD, DM (2) · Agnes Rethy, MD (1) · Ahmed Dabour, MD, Ph.D (1) · Ahmet Uygun, Prof (1) · Ajit Sood, DM (1) · Ala Sharara, MD (1) · Alexander Vahrmeijer, MD, PhD (1) · Alexandra Lavy, MD (1) · Almas Aamir, MSC (1) · Amy D Klion, M.D. (1) · Antonio Di Sabatino, MD (1) · Bilgi Baca, MD,Prof.Dr. (1) · Carlo M Taboada, MD (1) · Charles W Randall, MD (1)
PMID 26363929, PMID 40013523, PMID 24566744, PMID 25451666, PMID 25954111, PMID 26146498, PMID 26209030, PMID 28422836, PMID 28710882, PMID 30972640, PMID 31178342, PMID 32282545, PMID 32790844, PMID 32889959, PMID 32955197, PMID 33006765, PMID 33058137, PMID 33064186, PMID 33676969, PMID 33704071, PMID 35045559, PMID 35274092, PMID 35283330, PMID 35365509, PMID 35606544, PMID 35673354, PMID 35962454, PMID 36143388, PMID 37493095, PMID 38137669, PMID 39109266, PMID 39151436, PMID 39281978, PMID 40120806, PMID 40243391, PMID 40890737
2005 (1), 2023 (1), K08HD052885 (1)